Schedule 13G ownership disclosure

Veracyte Inc

Common Stock · CUSIP: 92337F107

Event date: 2025-07-31

Filing-level shares
11,930,018.00
Percent of class
15.2%
  • BlackRock, Inc.

    Shares: 11,930,018.00 · Class: 15.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002052113-25-003375
Form type
SCHEDULE 13G/A
Filer
BlackRock, Inc.
CIK
CIK 2012383
Filed
Aug 01, 2025
Reporting period
Jul 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub